Seer (SEER) EBIT (2020 - 2026)
Seer (SEER) recorded quarterly EBIT of -$17.3 million in Q1 2026, up 0.74% quarter-over-quarter from -$17.4 million in Q4 2025, and up 16.76% on a YoY basis from -$14.8 million in Q1 2025.
Seer (SEER) EBIT (2020 - 2026) Analysis & Trends
Seer's EBIT history runs 7 years deep, the most recent figure standing at -$17.3 million for Q1 2026.
- In Q1 2026, EBIT rose 16.76% year-over-year to -$17.3 million; the TTM figure through Mar 2026 stood at -$74.5 million (down 443.72% YoY), while the FY2025 annual figure was -$78.0 million, down 329.33% from the prior year.
- EBIT was -$17.3 million for Q1 2026 at Seer, up from -$17.4 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $63.1 million in Q4 2023 to a low of -$27.9 million in Q2 2023.
- Historically, EBIT has averaged -$13.5 million across 5 years, with a median of -$23.8 million in 2022.
- The sharpest annual moves came in 2023 and 2025: EBIT soared 352.97% in 2023, then plunged 129.74% in 2025.
- A 5-year view of EBIT shows it stood at -$24.9 million in 2022, then jumped by 352.97% to $63.1 million in 2023, then decreased by 7.39% to $58.4 million in 2024, then plunged by 129.74% to -$17.4 million in 2025, then climbed by 0.74% to -$17.3 million in 2026.
- The last three EBIT figures came in at -$17.3 million (Q1 2026), -$17.4 million (Q4 2025), and -$19.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | -17.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.26 Mn |
| Dec 31, 2025 | -17.39 Mn |
| Sep 30, 2025 | -19.35 Mn |
| Jun 30, 2025 | -20.53 Mn |
| Mar 31, 2025 | -20.73 Mn |
| Dec 31, 2024 | 58.45 Mn |
| Sep 30, 2024 | -24.33 Mn |
| Jun 30, 2024 | -27.10 Mn |
| Mar 31, 2024 | -25.19 Mn |
| Dec 31, 2023 | 63.11 Mn |
| Sep 30, 2023 | -25.85 Mn |
| Jun 30, 2023 | -27.94 Mn |
| Mar 31, 2023 | -27.45 Mn |
| Dec 31, 2022 | -24.95 Mn |
| Sep 30, 2022 | -25.07 Mn |
| Jun 30, 2022 | -23.43 Mn |
| Mar 31, 2022 | -23.79 Mn |
| Dec 31, 2021 | -19.87 Mn |
| Sep 30, 2021 | -18.43 Mn |
| Jun 30, 2021 | -16.67 Mn |